PRINCETON, N.J., February 12, 2001 -- Orchid BioSciences, Inc. (Nasdaq: ORCH) will present its leading single nucleotide polymorphism (SNP) analysis technology, SNP-IT, at the IBC Pharmacogenomics, SNPs & Genetic Patenting Conference in San Diego on February 13, 2001. For more information on the conference, please visit http://www.ibc-lifesci.com/usc/2611
Michael Boyce-Jacino, Ph.D., Chief Technology Officer and Vice President, R&D, Orchid BioSciences, Inc.
Dr. Boyce-Jacino is among the pioneers in the field of SNPs. Over the last decade, Dr. Boyce-Jacino has developed leading technologies for SNP analysis and conducted pioneering research in human SNPs. It was Dr. Boyce-Jacinos group that coined the term "single nucleotide polymorphisms, or SNPs" in the early 1990s.Where:
IBC Pharmacogenomics, SNPs & Genetics Patenting Conference Sheraton San Diego Hotel and Marina San Diego, CAWhen:
Tuesday, February 13, 2001 11:00 AM PST, 2:00 PM ESTTV producers: Video B-roll of Orchids technology is also available.
Background on Dr. Michael Boyce-Jacino
Dr. Boyce-Jacino has served as vice president of research and development of Orchid since 1998 and has served as chief technology officer since January 2001. From 1991 until it was acquired by Orchid in 1998, Dr. Boyce-Jacino served in a number of senior positions at Molecular Tool, where he was most recently president. Molecular Tool pioneered the first innovative technologies for SNP analysis in the early 1990s. Dr. Boyce-Jacino has more than 15 years of scientific experience in molecular genetics and biochemistry and holds numerous patents for his work in genotyping technologies. While at Molecular Tool, Dr. Boyce-Jacino led
Contact: Ernie Knewitz
212-696-4455 x. 204